256 related articles for article (PubMed ID: 6888821)
1. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.
Gambrell RD; Maier RC; Sanders BI
Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821
[TBL] [Abstract][Full Text] [Related]
2. Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM
Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050
[TBL] [Abstract][Full Text] [Related]
3. Cancer and the use of estrogens.
Gambrell RD
Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
[TBL] [Abstract][Full Text] [Related]
4. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
5. Use of progestogens in postmenopausal women.
Gambrell RD
Int J Fertil; 1989; 34(5):315-21. PubMed ID: 2571591
[TBL] [Abstract][Full Text] [Related]
6. Estrogen therapy and breast cancer in postmenopausal women.
Gambrell RD; Massey FM; Castaneda TA; Boddie AW
J Am Geriatr Soc; 1980 Jun; 28(6):251-7. PubMed ID: 7372968
[TBL] [Abstract][Full Text] [Related]
7. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
8. Hormones in the etiology and prevention of breast and endometrial cancer.
Gambrell RD
South Med J; 1984 Dec; 77(12):1509-15. PubMed ID: 6505760
[TBL] [Abstract][Full Text] [Related]
9. Hormones and breast cancer.
ESHRE Capri Workshop Group
Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of progestins in the menopausal patient: dosage and duration.
Gambrell RD
J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
[TBL] [Abstract][Full Text] [Related]
11. Estrogen use and cancer of the uterine corpus in Alberta.
Wigle DT; Grace M; Smith ES
Can Med Assoc J; 1978 May; 118(10):1276-8. PubMed ID: 647548
[TBL] [Abstract][Full Text] [Related]
12. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
[TBL] [Abstract][Full Text] [Related]
13. Sex steroids and cancer.
Gambrell RD
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluating the role of progestogen therapy after the menopause.
Henderson BE; Ross RK; Lobo RA; Pike MC; Mack TM
Fertil Steril; 1988 May; 49(5 Suppl 2):9S-15S. PubMed ID: 3360188
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
17. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
18. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
19. Exogenous estrogens and development of breast and endometrial cancer.
Vakil DV; Morgan RW; Halliday M
Cancer Detect Prev; 1983; 6(4-5):415-24. PubMed ID: 6652636
[TBL] [Abstract][Full Text] [Related]
20. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
